TY - JOUR
T1 - Assessing Amyloid Pathology in Cognitively Normal Subjects Using 18 F-Flutemetamol PET
T2 - Comparing Visual Reads and Quantitative Methods
AU - Collij, Lyduine E.
AU - Konijnenberg, Elles
AU - Reimand, Juhan
AU - Kate, Mara Ten
AU - Braber, Anouk den
AU - Alves, Isadora Lopes
AU - Zwan, Marissa
AU - Yaqub, Maqsood
AU - van Assema, Daniëlle M.E.
AU - Wink, Alle Meije
AU - Lammertsma, Adriaan A.
AU - Scheltens, Philip
AU - Visser, Pieter Jelle
AU - Barkhof, Frederik
AU - van Berckel, Bart N.M.
PY - 2019/5
Y1 - 2019/5
N2 - Our objective was to determine the optimal approach for assessing amyloid disease in a cognitively normal elderly population. Methods: Dynamic 18F-flutemetamol PET scans were acquired using a coffee-break protocol (a 0- to 30-min scan and a 90- to 110-min scan) on 190 cognitively normal elderly individuals (mean age, 70.4 y; 60% female). Parametric images were generated from SUV ratio (SUVr) and nondisplaceable binding potential (BPND) methods, with cerebellar gray matter as a reference region, and were visually assessed by 3 trained readers. Interreader agreement was calculated using κ-statistics, and semiquantitative values were obtained. Global cutoffs were calculated for both SUVr and BPND using a receiver-operating-characteristic analysis and the Youden index. Visual assessment was related to semiquantitative classifications. Results: Interreader agreement in visual assessment was moderate for SUVr (κ = 0.57) and good for BPND images (κ = 0.77). There was discordance between readers for 35 cases (18%) using SUVr and for 15 cases (8%) using BPND, with 9 overlapping cases. For the total cohort, the mean (±SD) SUVr and BPND were 1.33 (±0.21) and 0.16 (±0.12), respectively. Most of the 35 cases (91%) for which SUVr image assessment was discordant between readers were classified as negative based on semiquantitative measurements. Conclusion: The use of parametric BPND images for visual assessment of 18F-flutemetamol in a population with low amyloid burden improves interreader agreement. Implementing semiquantification in addition to visual assessment of SUVr images can reduce false-positive classification in this population.
AB - Our objective was to determine the optimal approach for assessing amyloid disease in a cognitively normal elderly population. Methods: Dynamic 18F-flutemetamol PET scans were acquired using a coffee-break protocol (a 0- to 30-min scan and a 90- to 110-min scan) on 190 cognitively normal elderly individuals (mean age, 70.4 y; 60% female). Parametric images were generated from SUV ratio (SUVr) and nondisplaceable binding potential (BPND) methods, with cerebellar gray matter as a reference region, and were visually assessed by 3 trained readers. Interreader agreement was calculated using κ-statistics, and semiquantitative values were obtained. Global cutoffs were calculated for both SUVr and BPND using a receiver-operating-characteristic analysis and the Youden index. Visual assessment was related to semiquantitative classifications. Results: Interreader agreement in visual assessment was moderate for SUVr (κ = 0.57) and good for BPND images (κ = 0.77). There was discordance between readers for 35 cases (18%) using SUVr and for 15 cases (8%) using BPND, with 9 overlapping cases. For the total cohort, the mean (±SD) SUVr and BPND were 1.33 (±0.21) and 0.16 (±0.12), respectively. Most of the 35 cases (91%) for which SUVr image assessment was discordant between readers were classified as negative based on semiquantitative measurements. Conclusion: The use of parametric BPND images for visual assessment of 18F-flutemetamol in a population with low amyloid burden improves interreader agreement. Implementing semiquantification in addition to visual assessment of SUVr images can reduce false-positive classification in this population.
KW - 18F-flutemetamol PET
KW - amyloid pathology
KW - preclinical Alzheimer disease
KW - visual assessment
UR - http://www.scopus.com/inward/record.url?scp=85064189230&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064189230&partnerID=8YFLogxK
U2 - 10.2967/jnumed.118.211532
DO - 10.2967/jnumed.118.211532
M3 - Article
C2 - 30315145
AN - SCOPUS:85064189230
SN - 0161-5505
VL - 60
SP - 541
EP - 547
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
IS - 5
ER -